BIOLASE, INC Quarterly Other Assets, Noncurrent in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Biolase, Inc quarterly Other Assets, Noncurrent history and growth rate from Q4 2010 to Q2 2024.
  • Biolase, Inc Other Assets, Noncurrent for the quarter ending June 30, 2024 was $257K, a 7.89% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $257K -$22K -7.89% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $263K +$6K +2.34% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $268K +$13K +5.1% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $270K +$36K +15.4% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $279K +$38K +15.8% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $257K +$26K +11.3% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $255K +$35K +15.9% Dec 31, 2022 10-K 2024-03-21
Q3 2022 $234K +$12K +5.41% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $241K +$16K +7.11% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $231K +$5K +2.21% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $220K -$11K -4.76% Dec 31, 2021 10-K 2023-03-28
Q3 2021 $222K +$2K +0.91% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $225K -$281K -55.5% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $226K -$258K -53.3% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $231K -$202K -46.7% Dec 31, 2020 10-K 2022-03-17
Q3 2020 $220K -$498K -69.4% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 $506K -$287K -36.2% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $484K +$182K +60.3% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $433K +$125K +40.6% Dec 31, 2019 10-K 2021-03-31
Q3 2019 $718K +$349K +94.6% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $793K +$389K +96.3% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $302K -$148K -32.9% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $308K -$26K -7.78% Dec 31, 2018 10-K 2020-03-30
Q3 2018 $369K +$34K +10.1% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 $404K +$69K +20.6% Jun 30, 2018 10-Q 2018-08-13
Q1 2018 $450K +$117K +35.1% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 $334K -$216K -39.3% Dec 31, 2017 10-K 2019-03-08
Q3 2017 $335K -$216K -39.2% Sep 30, 2017 10-Q 2017-11-01
Q2 2017 $335K -$216K -39.2% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 $333K -$223K -40.1% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 $550K -$197K -26.4% Dec 31, 2016 10-K 2018-03-14
Q3 2016 $551K -$207K -27.3% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 $551K -$210K -27.6% Jun 30, 2016 10-Q 2016-08-01
Q1 2016 $556K -$402K -42% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 $747K +$477K +177% Dec 31, 2015 10-K 2017-03-10
Q3 2015 $758K +$490K +183% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 $761K +$501K +193% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $958K +$711K +288% Mar 31, 2015 10-Q 2015-05-01
Q4 2014 $270K +$21K +8.43% Dec 31, 2014 10-K 2016-03-11
Q3 2014 $268K +$22K +8.94% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 $260K +$15K +6.12% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 $247K -$35K -12.4% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 $249K -$56K -18.4% Dec 31, 2013 10-K 2015-03-06
Q3 2013 $246K -$110K -30.9% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $245K -$135K -35.5% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 $282K +$95K +50.8% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 $305K +$118K +63.1% Dec 31, 2012 10-K 2014-03-17
Q3 2012 $356K +$170K +91.4% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $380K +$195K +105% Jun 30, 2012 10-Q/A 2012-09-06
Q1 2012 $187K Mar 31, 2012 10-Q 2012-05-10
Q4 2011 $187K +$17K +10% Dec 31, 2011 10-K 2013-03-15
Q3 2011 $186K Sep 30, 2011 10-Q 2011-11-10
Q2 2011 $185K Jun 30, 2011 10-Q 2011-08-11
Q4 2010 $170K Dec 31, 2010 10-K 2012-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.